Literature DB >> 17003933

Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy.

Gábor Széplaki1, Lilian Varga, Judit Laki, Edit Dósa, Hans O Madsen, Zoltán Prohászka, Attila Szabó, György Acsády, László Selmeci, Peter Garred, George Füst, László Entz.   

Abstract

Early restenosis following carotid endarterectomy (CEA) is an inflammatory process leading to myointimal hyperplasia of smooth muscle cells. The risk for restenosis is increased in homozygous carriers of the normal (A) allele of mannose-binding lectin (MBL2) gene. Our objective was to study the associations of C3 and as control three non-complement acute-phase reactants (APRs) (C-reactive protein, haptoglobin and alpha2HSglycoprotein) with early restenosis following CEA. We also considered, whether MBL2 genotype relates to C3 levels and to the risk of restenosis. Concentrations of the APRs were determined by radial immunodiffusion or immunoturbidimetric methods in 64 patients who underwent eversion CEA and were followed up with carotid duplex scan (CDS) examinations for at least one year. MBL2 genotypes were determined by a PCR-SSP method. C3 levels increased during the follow-up and correlated with the percentage of restenosis detected by CDS at 14 months postsurgery, in MBL2 A/A allele carriers. Patients with high C3 levels had nearly five-fold higher odds for the presence of significant restenosis (>50% reduction in diameter) even after adjusting for MBL2 genotype, age and gender. By contrast, no such associations were detected between the non-complement APRs and early restenosis. C3 is associated with and might have a direct role in the development of an early restenosis following CEA, which is partially related to an intact MBL lectin pathway, thus determining C3 levels might have clinical importance. On the other hand, our results indicate that the regulation of C3 differs from non-complement APRs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003933

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.

Authors:  Thiruma V Arumugam; Sung-Chun Tang; Justin D Lathia; Aiwu Cheng; Mohamed R Mughal; Srinivasulu Chigurupati; Tim Magnus; Sic L Chan; Dong-Gyu Jo; Xin Ouyang; David P Fairlie; Daniel N Granger; Alexander Vortmeyer; Milan Basta; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

2.  The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery.

Authors:  Charles D Collard; Stanton K Shernan; Amanda A Fox; Toralf Bernig; Stephen J Chanock; William K Vaughn; Kazue Takahashi; Alan B Ezekowitz; Petr Jarolim; Simon C Body
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

3.  Restenosis and therapy.

Authors:  Laszlo Denes; Laszlo Entz; Veronika Jancsik
Journal:  Int J Vasc Med       Date:  2012-02-23

4.  High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.

Authors:  Zsolt Bagyura; Loretta Kiss; Balázs Berta; Ágnes Szilágyi; Kristóf Hirschberg; Gábor Széplaki; Árpád Lux; Zsolt Szelid; Pál Soós; Béla Merkely
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

Review 5.  Complement activation: an emerging player in the pathogenesis of cardiovascular disease.

Authors:  Angela M Carter
Journal:  Scientifica (Cairo)       Date:  2012-12-16

Review 6.  The management of carotid restenosis: a comprehensive review.

Authors:  Francesco Stilo; Nunzio Montelione; Rosalinda Calandrelli; Marisa Distefano; Francesco Spinelli; Vincenzo Di Lazzaro; Fabio Pilato
Journal:  Ann Transl Med       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.